default author photo

Hiroki Izumi

National Cancer Center Hospital East

SCHOLARLY PAPERS

3

DOWNLOADS

137

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Daily low-dose carboplatin or weekly carboplatin plus nab-paclitaxel for concurrent chemoradiotherapy in older patients with locally advanced non-small cell lung cancer (JCOG1914): A randomized phase 3 trial

Number of pages: 42 Posted: 05 Dec 2025
affiliation not provided to SSRN, Shizuoka Cancer Center - Division of Thoracic Oncology, University of Tokyo - Department of Biostatistics and Bioinformatics, Shizuoka Cancer Center, affiliation not provided to SSRN, Shizuoka Cancer Center, Nagoya University, National Cancer Center Hospital East, National Cancer Center Hospital, National Hospital Organization Nagoya Medical Center, Hiroshima University - Hiroshima University Hospital, Kurashiki Central Hospital - Department of Respiratory Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, Kanagawa Cancer Center, affiliation not provided to SSRN, Kansai Medical University, Kurume University - Department of Internal Medicine, Kyushu University, National Center for Global Health and Medicine, Niigata Cancer Center Hospital, Osaka City General Hospital, Kyoto University, affiliation not provided to SSRN, National Cancer Center Hospital, National Cancer Center Hospital, Kyushu University - Kyushu University Hospital and Shizuoka Cancer Center
Downloads 57 (1,031,043)

Abstract:

Loading...

locally advanced, Non-small cell lung cancer (NSCLC), older patients, chemoradiotherapy, daily low-dose carboplatin, carboplatin plus nab-paclitaxel

2.

Large-Scale Clinico-Genomic Profile of Non-Small Cell Lung Cancer with KRAS G12C: Results from LC-SCRUM-Asia Study

Number of pages: 34 Posted: 09 Dec 2022
National Cancer Center Hospital East, National Cancer Center Hospital East, National Cancer Center Hospital East, National Cancer Center Hospital East, National Cancer Center Hospital East, National Cancer Center Hospital East, Kanagawa Cancer Center, Osaka International Cancer Institute, Sendai Kousei Hospital, St. Marianna University School of Medicine, Japanese Red Cross Medical Center, National Hospital Organization (NHO) - Iwakuni Clinical Center, University of Tokyo - Department of Biostatistics and Bioinformatics, National Cancer Center Hospital East, National Cancer Center Hospital East, National Cancer Center Hospital East, National Cancer Center Hospital East, National Cancer Center Hospital East, National Cancer Center Hospital East, Nagoya University - Graduate School of Medicine and National Cancer Center Hospital East
Downloads 40 (1,209,354)

Abstract:

Loading...

Non-small cell lung cancer, KRAS mutation, KRAS G12C, Next-generation sequencing, Tumor burden, PD-L1 expression

3.

The Impact of Tertiary Lymphoid Structures on Clinicopathological, Genetic and Gene Expression Characteristics in Lung Adenocarcinoma

Number of pages: 27 Posted: 21 May 2022
National Cancer Center Hospital East, National Cancer Center Hospital East, affiliation not provided to SSRN, National Cancer Center, Japan - Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Japan - Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Hospital East - Department of Thoracic Surgery, National Cancer Center Hospital East, National Cancer Center Hospital East, National Cancer Center Hospital East, National Cancer Center Hospital East, National Cancer Center Hospital East, National Cancer Center Hospital East, National Cancer Center Hospital East, Department of Pathology, Nagoya University Graduate School of Medicine, National Cancer Center Hospital East, National Cancer Center Hospital East, National Cancer Center Hospital East, National Cancer Center Hospital East, National Cancer Center Hospital East, Nagoya University - Graduate School of Medicine, National Cancer Center Hospital East - Department of Thoracic Surgery, National Cancer Center Hospital East and National Cancer Center Hospital East
Downloads 40 (1,183,237)

Abstract:

Loading...

Tertiary lymphoid structures, Lung adenocarcinoma, PD-L1 expression, Tumor mutation burden, Gene expression analysis